p66ShcA modulates tissue response to hindlimb ischemia

Circulation

Volumn 109, Issue 23, 2004, Pages 2917-2923

  Zaccagnini, Germana ^b   Martelli, Fabio ^a   Fasanaro, Pasquale ^a   Magenta, Alessandra ^a   Gaetano, Carlo ^d   Di Carlo, Anna ^b   Biglioli, Paolo ^b   Giorgio, Marco ^c   Martin Padura, Ines ^c   Pelicci, Pier Giuseppe ^c   Capogrossi, Maurizio C ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d NONE

Author keywords

Apoptosis; Free radicals; Ischemia; Muscles; Reperfusion

Indexed keywords

PROTEIN P66; PROTEIN P66 SHCA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY DISSECTION; ARTICLE; CAPILLARY; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; ENDOTHELIUM CELL; FEMORAL ARTERY; HEMOPERFUSION; IN VITRO STUDY; IN VIVO STUDY; LEG ISCHEMIA; MALE; MOUSE; MOUSE STRAIN; MUSCLE CELL; MUSCLE NECROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN TARGETING; REPERFUSION INJURY; TISSUE INJURY; TISSUE REACTION; TOURNIQUET; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENETICS; HINDLIMB; ISCHEMIA; MOUSE MUTANT; NECROSIS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; VASCULARIZATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CAPILLARIES; CELLS, CULTURED; ENDOTHELIAL CELLS; HINDLIMB; ISCHEMIA; MALE; MICE; MICE, KNOCKOUT; MUSCLE CELLS; MUSCLE FIBERS; NECROSIS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16544365687     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000129309.58874.0F     Document Type: Article

References (33)

1. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol. 2002;282:C227-C241.
2. Gilgun-Sherki Y, Rosenbaum Z, Melamed E, et al. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev. 2002;54:271-284.
3. Becker LB, vanden Hoek TL, Shao ZH, et al. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol. 1999;277:H2240-H2246.
4. Vanden Hoek TL, Li C, Shao Z, et al. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol. 1997;29:2571-2583.
5. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A. 1987;84:1404-1407.
6. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A. 1988;85:4046-4050.
7. Arroyo CM, Kramer JH, Leiboff RH, et al. Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Radic Biol Med. 1987;3:313-316.
8. Bolli R, Patel BS, Jeroudi MO, et al. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest. 1988;82: 476-485.
9. Salvemini D, Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med. 2003;31:S29-S38.
10. Koksal C, Bozkurt AK, Cangel U, et al. Attenuation of ischemia/reperfusion injury by N-acetylcysteine in a rat hind limb model. J Surg Res. 2003;111:236-239.
11. Hirose J, Yamaga M, Kato T, et al. Effects of a hydroxyl radical scavenger, EPC-K1, and neutrophil depletion on reperfusion injury in rat skeletal muscle. Acta Orthop Scand. 2001;72:404-410.
12. Luzi L, Confalonieri S, Di Fiore PP, et al. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev. 2000;10:668-674.
13. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene. 2001;20:6322-6330.
14. Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999;402:309-313.
15. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002;295:2450-2452.
16. Trinei M, Giorgio M, Cicalese A, et al. p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidafion-damaged DNA and oxidative stress-induced apoptosis. Oncogene. 2002;21:3872-3878.
17. Napoli C, Martin-Padura I, de Nigris F, et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A. 2003;100:2112-2116.
18. Turrini P, Gaetano C, Antonelli A, et al. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett. 2002;323:109-112.
19. Emanueli C, Zacheo A, Minasi A, et al. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler Thromb Vasc Biol. 2000;20:2379-2385.
20. Martelli F, Livingston DM. Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. Proc Natl Acad Sci U S A. 1999;96:2858-2863.
21. Royall JA, Ischiropoulos H. Evaluation of 2′,7′- dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys. 1993;302:348-355.
22. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol. 1998;108:107-110.
23. Levine RL, Williams JA, Stadtman ER, et al. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346-357.
24. Couffinhal T, Silver M, Zheng LP, et al. Mouse model of angiogenesis. Am J Pathol. 1998;152:1667-1679.
25. Thurston G, Baluk P, Hirata A, et al. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol. 1996;271:H2547-H2562.
26. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999;77:527-543.
27. Hatoko M, Tanaka A, Kuwahara M, et al. Difference of molecular response to ischemia-reperfusion of rat skeletal muscle as a function of ischemic time: study of the expression of p53, p21(WAF-1), Bax protein, and apoptosis. Ann Plast Surg. 2002;48:68-74.
28. Andoh T, Lee SY, Chiueh CC. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. Faseb J. 2000;14:2144-2146.
29. Cesselli D, Jakoniuk I, Barlucchi L, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res. 2001;89:279-286.
30. Kops GJ, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316-321.
31. Morrison RS, Kinoshita Y. The role of p53 in neuronal cell death. Cell Death Differ. 2000;7:868-879.
32. Lai KM, Pawson T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev. 2000;14:1132-1145.
33. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253.